Open Access

[Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway

  • Authors:
    • Zhi Teng
    • Shijuan Xu
    • Qin Lei
  • View Affiliations

  • Published online on: March 11, 2024     https://doi.org/10.3892/or.2024.8725
  • Article Number: 66
  • Copyright : © Teng et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

May-2024
Volume 51 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Teng Z, Xu S and Lei Q: [Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 <em>in vivo</em> and <em>in vitro</em> by inhibiting the PI3K/AKT/mTOR signaling pathway. Oncol Rep 51: 66, 2024
APA
Teng, Z., Xu, S., & Lei, Q. (2024). [Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 <em>in vivo</em> and <em>in vitro</em> by inhibiting the PI3K/AKT/mTOR signaling pathway. Oncology Reports, 51, 66. https://doi.org/10.3892/or.2024.8725
MLA
Teng, Z., Xu, S., Lei, Q."[Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 <em>in vivo</em> and <em>in vitro</em> by inhibiting the PI3K/AKT/mTOR signaling pathway". Oncology Reports 51.5 (2024): 66.
Chicago
Teng, Z., Xu, S., Lei, Q."[Retracted] Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 <em>in vivo</em> and <em>in vitro</em> by inhibiting the PI3K/AKT/mTOR signaling pathway". Oncology Reports 51, no. 5 (2024): 66. https://doi.org/10.3892/or.2024.8725